05/15/2026
Health Canada has officially approved generic versions of semaglutide — and this could be a major step forward for accessibility.
For many people, the biggest barrier to GLP-1 medications has been cost, especially when they’re being used as part of a longer-term health strategy, whether at a full therapeutic dose or through a more individualized microdosing approach.
While exact pricing is still unknown, experts are estimating potential savings anywhere from 30–50%, with some projections as high as 75% as more generic options enter the market.
So when will they be widely available? Likely not immediately. With demand expected to be high, broader access may not happen until mid-summer to early fall.
But what does this mean if you’re already on semaglutide — or thinking about it?
It means more options may be coming. More affordability. More long-term sustainability. And more opportunity to explore whether this tool fits into your bigger health plan.
If you’ve been on the fence about looking into medical weight loss or our Body Optimization Program, there has never been a better time to start the conversation.
Generic semaglutide doesn’t replace the need for proper screening, dosing, monitoring, nutrition, muscle preservation, and long-term planning — but it may make evidence-based care more accessible for many Canadians.
Send us a DM with BODY to learn more.
